March 2, 2020 / 8:53 PM / 3 months ago

BRIEF-FDA Approves Sanofi-Aventis U.S.' Sarclisa

March 2 (Reuters) - FDA:

* FDA - APPROVES SANOFI-AVENTIS U.S.' SARCLISA, IN COMBINATION WITH POMALIDOMIDE, DEXAMETHASONE FOR PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA Source text for Eikon: [bit.ly/38apMsw] Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below